Skip to content
DataLookout
Menu

NCT05276856

Recovery Rate in Secondary Hypothyroidism

StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 31, 2025 to Dec 31, 2027 Show 6 more changesShow less
    • Eligibility criteria expanded, about 5 words
    • Trial status changed: Unknown → Active, Not Recruiting
    • Study completion pushed from Dec 31, 2025 to Dec 31, 2028
    • Study description expanded, about 9 words
    • Site details revised
    • Publications: details revised at 6 of 6 entries
  2. Minor Changed Registry marked status Unknown; last known: Recruiting
  3. Notable Primary and study completion dates pushed to Dec 31, 2025
    • Trial status: Not Yet Recruiting to Unknown
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 10, 2022 to Apr 4, 2022
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Percentage of patients achieving euthyroid status
Timeframe: 12 weeks

Arms and interventions

Drugs: Levothyroxine

Sites

1 site in 1 country

  • Nova Scotia HealthHalifax, Canada